Effectiveness and Safety of Autologous Virus-Specific T-Cell Therapy for Persistent COVID-19 in People With Immunocompromise: A Clinical Trial Study. (academic.oup.com)

Authors: Lee R … Lee DG Journal: Clinical Infectious Diseases Published: 2026-02-04 DOI: https://doi.org/10.1093/cid/ciaf302